{"log_id": 1748904633735187475, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.006553, "average": 0.967644, "min": 0.616425}, "location": {"width": 791, "top": 112, "height": 59, "left": 198}, "words": "淡漠、少语)。也可碱轻与精神分裂症有关的情感症状(如:抑郁、负罪感、焦虑)"}, {"probability": {"variance": 0.002505, "average": 0.985217, "min": 0.718584}, "location": {"width": 704, "top": 159, "height": 58, "left": 199}, "words": "对于急性期治疗有效的患者,在维持期治疗中,本可继续发挥其临床疗效"}, {"probability": {"variance": 0.000441, "average": 0.990266, "min": 0.887375}, "location": {"width": 862, "top": 198, "height": 65, "left": 158}, "words": "2.可用于治疗双相情感障碍的躁狂发作,其表现为情绪高涨、夸大或易激惹、自我评价过"}, {"probability": {"variance": 8.7e-05, "average": 0.99545, "min": 0.956895}, "location": {"width": 818, "top": 241, "height": 62, "left": 203}, "words": "高、睡眠要求减少、语速加快、思维奔逸、注意力分散或判断力低下(包括紊乱或过激"}, {"probability": {"variance": 5.1e-05, "average": 0.993101, "min": 0.983202}, "location": {"width": 57, "top": 317, "height": 25, "left": 205}, "words": "行为)"}, {"probability": {"variance": 0.000167, "average": 0.991744, "min": 0.969401}, "location": {"width": 91, "top": 360, "height": 28, "left": 160}, "words": "【规格】"}, {"probability": {"variance": 0.000548, "average": 0.977453, "min": 0.921205}, "location": {"width": 142, "top": 403, "height": 25, "left": 210}, "words": "(1)1mg(2)2mg"}, {"probability": {"variance": 0.000816, "average": 0.985632, "min": 0.921872}, "location": {"width": 144, "top": 478, "height": 31, "left": 165}, "words": "【用法用量】"}, {"probability": {"variance": 0.00057, "average": 0.986151, "min": 0.928286}, "location": {"width": 128, "top": 520, "height": 28, "left": 213}, "words": "1.精神分裂症"}, {"probability": {"variance": 0.017769, "average": 0.952922, "min": 0.455661}, "location": {"width": 816, "top": 530, "height": 64, "left": 216}, "words": "由使用其它抗精神病药改用本都者:开始使用时:应渐停原先使用的抗精神病药;若病"}, {"probability": {"variance": 0.007808, "average": 0.970298, "min": 0.562735}, "location": {"width": 871, "top": 573, "height": 65, "left": 161}, "words": "人原来使用的是长效抗精神病药,则可用本治疗来替代下一疗程的用药。已用的抗帕金森氏"}, {"probability": {"variance": 7.6e-05, "average": 0.997527, "min": 0.957778}, "location": {"width": 471, "top": 631, "height": 49, "left": 163}, "words": "综合症的药是否需要继续则应定期地进行重新评定"}, {"probability": {"variance": 0.002666, "average": 0.984371, "min": 0.691243}, "location": {"width": 813, "top": 658, "height": 60, "left": 222}, "words": "成人:每日1次或每口2次。起始剂量1mg,在1周左右的时间内逐渐将剂量加大到每"}, {"probability": {"variance": 0.007842, "average": 0.970701, "min": 0.512961}, "location": {"width": 871, "top": 698, "height": 67, "left": 166}, "words": "日2~4mg,第2周内可逐渐加量到每目4~6mg。此后,可维持此剂量不变,或根据个人情况"}, {"probability": {"variance": 0.011025, "average": 0.961585, "min": 0.457097}, "location": {"width": 753, "top": 746, "height": 61, "left": 166}, "words": "进一步调整。一般情况下,最适剂量为每口2~6mg。每日剂量一般不超过10mg"}, {"probability": {"variance": 0.008188, "average": 0.974856, "min": 0.636322}, "location": {"width": 304, "top": 842, "height": 44, "left": 221}, "words": "2.治疗双相情感障碍的躁狂发作"}, {"probability": {"variance": 0.007097, "average": 0.979244, "min": 0.459801}, "location": {"width": 818, "top": 863, "height": 63, "left": 225}, "words": "推荐起始剂量每日1次、每次1~2mg,剂量可根据个体需要进行调整。剂量增加的幅度"}, {"probability": {"variance": 0.032831, "average": 0.916861, "min": 0.355833}, "location": {"width": 851, "top": 903, "height": 70, "left": 175}, "words": "为每日1~2mg,剂量增加至少隔口或间隔更多数进行。蜜数患者的理想剂量为每2"}, {"probability": {"variance": 0.018855, "average": 0.944439, "min": 0.361146}, "location": {"width": 696, "top": 951, "height": 65, "left": 177}, "words": "6mg。在所有的对症治疗期间,应不断地对是否需要继续使本进行评价"}, {"probability": {"variance": 0.001528, "average": 0.986365, "min": 0.862812}, "location": {"width": 218, "top": 1015, "height": 39, "left": 228}, "words": "3.肝肾功能损害的患者"}, {"probability": {"variance": 0.017557, "average": 0.955062, "min": 0.390521}, "location": {"width": 821, "top": 1029, "height": 69, "left": 230}, "words": "肾功能损害患者清除抗精神病药物的能力低于健康成人肝功能损害患者血浆中游离利"}, {"probability": {"variance": 0.008214, "average": 0.956036, "min": 0.672229}, "location": {"width": 872, "top": 1072, "height": 73, "left": 181}, "words": "培酮的浓度有所增加。无论何种适应症,肾助能损害患者或肝功能损害患者的起始及维持剂量"}, {"probability": {"variance": 0.009812, "average": 0.970359, "min": 0.531389}, "location": {"width": 482, "top": 1131, "height": 55, "left": 184}, "words": "应减半,剂量调整应减缓。此类患者在使用本时"}, {"probability": {"variance": 0, "average": 0.99993, "min": 0.999807}, "location": {"width": 146, "top": 1229, "height": 35, "left": 192}, "words": "【不良反应】"}, {"probability": {"variance": 1e-05, "average": 0.997859, "min": 0.991055}, "location": {"width": 130, "top": 1275, "height": 30, "left": 207}, "words": "临床试验数据"}, {"probability": {"variance": 0.000582, "average": 0.992649, "min": 0.847328}, "location": {"width": 822, "top": 1280, "height": 67, "left": 240}, "words": "在一项临床试验中评价本品的安全性,9712例不同类型的精神病患者包括成人、老年"}, {"probability": {"variance": 0.00466, "average": 0.978606, "min": 0.57256}, "location": {"width": 872, "top": 1321, "height": 70, "left": 190}, "words": "痴呆患者和儿童)至少接受本品一个剂量的治疗。其中2626例患者在参加双盲、安慰剂对照"}, {"probability": {"variance": 0.008754, "average": 0.972392, "min": 0.529832}, "location": {"width": 871, "top": 1361, "height": 72, "left": 193}, "words": "试验时接受了本品的治疗。在治疗状况和持续时间上有很大的区别,包括双盲、定量和不定"}, {"probability": {"variance": 5.7e-05, "average": 0.996199, "min": 0.969075}, "location": {"width": 874, "top": 1403, "height": 71, "left": 194}, "words": "量、安慰剂或活性对照试验和开放期试验的住院和门诊患者,短期(至12周)和长期(至3"}, {"probability": {"variance": 0.000238, "average": 0.990435, "min": 0.949486}, "location": {"width": 191, "top": 1478, "height": 38, "left": 201}, "words": "年)给药(交叉分类"}, {"probability": {"variance": 0.000567, "average": 0.967758, "min": 0.943194}, "location": {"width": 200, "top": 1546, "height": 33, "left": 176}, "words": " CCDS +aug--jan 08"}], "language": 3}